CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
preoperative infusion of levosimendan +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04635293
NCT04635293N/ACompleted
CompareCT.gov

Preoperative Infusion of Levosimendan in High Risk Cardiac Surgery Patients: A Retrospective Study

Aretaieion University Hospital·interventional·Posted Nov 19, 2020·Updated Nov 19, 2020

In Brief

A clinical study evaluating preoperative infusion of levosimendan and no preoperative infusion of levosimendan for Cardiac Disease and 4 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The aim of this retrospective study will be to investigate the effect of the preoperative administration of levosimendan on the outcome of patients with compromised cardiac function undergoing cardiac surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Disease, Cardiac Failure, Cardiac Surgery, Inotropes, Ejection Fraction
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2020
Enrollment StartJan 1, 2012
Primary CompletionNov 9, 2020
TodayJul 2, 2026
Enrollment to primary: 8.9 yearsPosted 5.6 years ago

Interventions

preoperative infusion of levosimendanprocedure

the study group will consist of patients who have received a continuous infusion of levosimendan 0.1 μg/kg/min for 24 hours before cardiac surgery

no preoperative infusion of levosimendanprocedure

the control group will consist of patients who proceeded to the cardiac operation without any infusion for 24 hours preoperatively